Comparison between plasma mycophenolic acid concentrations determined by liquid chromatography-tandem mass spectrometry and particle-enhanced turbidimetric inhibition immunoassay methods

Comparison between plasma mycophenolic acid concentrations determined by liquid chromatography-tandem mass spectrometry and particle-enhanced turbidimetric inhibition immunoassay methods - Comparison between plasma mycophenolic acid concentrations determined by liquid chromatography-tandem mass spectrometry and particle-enhanced turbidimetric inhibition immunoassay methods

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018615

Enrollment

Registered

2015-08-10

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung transplantation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: After lung transplant surgery In hospital The plasma mycophenolic acid concentration is measured by LC/MS/MS method

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

Measure	Time frame
The equivalency of plasma mycophenolic acid concentration	—

Countries

Japan

Contacts

Public ContactHiroaki Yamaguchi

Tohoku university hospital Department of pharmaceutical sciences

yamaguchi@hosp.tohoku.ac.jp022-717-7528

Outcome results